A Phase 1/2 Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric and Young Adult Solid Tumors
Julie Krystal, Steven G. DuBois, Tanya Watt, Rajen J. Mody et al.
Citations
1 citations
Journal
Pediatric Blood & Cancer
Topics
Neuroblastoma Research and Treatments
Field-Weighted Citation Impact (FWCI)
1.39
article
A Phase 1/2 Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric and Young Adult Solid Tumors
Julie Krystal, Steven G. DuBois, Tanya Watt, Rajen J. Mody, Chinyere E. Okpara, Frank M. Balis, Daniel A. Morgenstern, Karen O’Hara, James M. Croop, AeRang Kim, Brenda J. Weigel, Elizabeth Fox, Margaret E. Macy, Filemon S. Dela Cruz, Joseph G. Pressey, Kieuhoa T. Vo, Julia Glade Bender, Theodore W. Laetsch, Gregory K. Friedman, Jagadeesh Aluri, Cixin He
article en
1 citations
Abstract
No abstract available for this paper.
Publication Tag
Pediatric Blood & CancerVol. 72(7)
Institutions
Cincinnati Children's Hospital Medical Center (US), University of Minnesota (US), St. Jude Children's Research Hospital (US), Memorial Sloan Kettering Cancer Center (US), Children's Hospital of Philadelphia (US), The University of Texas MD Anderson Cancer Center (US), Harvard University (US), University of California, San Francisco (US), University of Toronto (CA), Hospital for Sick Children (CA), Riley Hospital for Children (US), University of Alabama at Birmingham (US), Children's Hospital Colorado (US), Center for Cancer and Blood Disorders (US), Cohen Children's Medical Center (US), UCSF Benioff Children's Hospital (US), SickKids Foundation (CA), Eisai (United Kingdom) (GB), Eisai (United States) (US), C. S. Mott Children's Hospital (US), Dana-Farber/Boston Children's Cancer and Blood Disorders Center (US), University of Pennsylvania (US), The University of Texas Southwestern Medical Center (US), University of Colorado Denver (US)